Vimarsana
Biggest News Aggregation in the World

Page 22 - Venture Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Venture Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Venture Development Today - Breaking & Trending Today

Thuduc House muốn thoái sạch vốn công ty liên doanh với Daewon sau 14 năm hợp tác - Vimarsana News

Thuduc House muốn thoái sạch vốn công ty liên doanh với Daewon sau 14 năm hợp tác

HĐQT Công ty Cổ phần Phát triển Nhà Thủ Đức - Thuduc House (HoSE: TDH) vừa thông qua chủ trương chuyển nhượng toàn bộ cổ phần tại Công ty Cổ phần Phát triển Nhà Daewon - Thủ Đức.

Source: antt.vn
TendoNova Receives GRA Phase III Commercialization Funding - Vimarsana News

TendoNova Receives GRA Phase III Commercialization Funding

Georgia Research Alliance Support Enables Production Ramp Up...

NJEDA adds new accelerator to help state-based startups - Vimarsana News

NJEDA adds new accelerator to help state-based startups

NJEDA adds new accelerator to help state-based startups June 3, 2021 1:11 pm The New Jersey Economic Development Authority is adding its third participant to a new incentive program meant to attract and grow startups in the state, known as NJ Accelerate. An accelerator is a type of fixed-term “cohort program,” spanning 15 to 20 weeks, where entrepreneurs are given access to facilities, offices, lab space, seed funding, mentoring and technical assistance to hash out and refine their business proposal, which they then eventually pitch, said NJEDA Executive Vice President Kathleen Coviell...

Source: njbiz.com
Intratumoral SIRPalpha-deficient macrophages activate tumor-specific cytotoxic T cells - Vimarsana News

Intratumoral SIRPalpha-deficient macrophages activate tumor-specific cytotoxic T cells

In a study that will be published in Nature Communications on May 28, 2021, a research team led by Dr. Yuan Liu from Georgia State University reports that intratumoral SIRPalpha-deficient macrophages activate tumor antigen-specific cytotoxic T cells to eliminate various syngeneic cancers under radiotherapy. Their study identifies SIRPalpha as a master regulator controling macrophage immune responses and has demonstrated that intratumoral injection of SIRPalpha-depleted macrophages combined with local radiation is an effective strategy to treat different tumors

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation - Vimarsana News

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation Share Article Dr. Dennis Liotta and Dr. Paul Atkins “They are both innovative, life science veterans that have taken impactful technologies from the earliest stage to highly successful exits and we are fortunate to have them on our team.” said Calvin Goforth, Chief Executive Officer of VIC. FAYETTEVILLE, Ark. (PRWEB) May 17, 2021 VIC Technology Venture Development, which crea...

Source: prweb.com